Market Tracker

09/30 6:07am ET

Impax Laboratories Inc (NASDAQ:IPXL)

24.34
Data as of Sep 29
 0.00 / 0.00%
Today’s Change
19.39
Today|||52-Week Range
31.04
-3.18%
Year-to-Date

Today’s Trading

Previous close24.34
Today’s open24.12
Day’s range-- - --
Volume409,307
Average volume (3 months)660,248
Market cap$1.7B
Dividend yield--
Data as of 09/29/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+41.42%
Earnings growth (next 5 years)+26.24%
Revenue growth (last year)-12.07%
P/E ratio1,217.0
Price/Sales3.29
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc+1.19+1.86%
GWPHGW Pharmaceuticals P...+1.22+1.44%
IRWDIronwood Pharmaceuti...+0.40+3.08%
RAREUltragenyx Pharmaceu...+2.57+4.49%
Data as of 09/29/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.31
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts